Marius Pharmaceuticals Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $6.01M

  • Investors
  • 1

Marius Pharmaceuticals General Information

Description

Developer of an oral testosterone replacement therapy designed for hypogonadism or testosterone deficiency. The company's therapy helps to overcome the problems associated with currently approved products, and their proprietary delivery technology has achieved optimal absorption with all meal types, resulting in a higher bioavailability, and improving the functional lives of patients by reducing the downstream effects of deficiency, which include multiple comorbidities, enabling men suffering from low testosterone to get safe and efficacious treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2301 Sugar Bush Road
  • Suite 510
  • Raleigh, NC 27612
  • United States
+1 (919)
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Corporate Office
  • 2301 Sugar Bush Road
  • Suite 510
  • Raleigh, NC 27612
  • United States
+1 (919)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Marius Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 05-Oct-2021 $6.01M Completed Clinical Trials - Phase 3
3. Early Stage VC (Series A2) 01-Jan-2020 Completed Clinical Trials - Phase 3
2. Early Stage VC (Series A1) 25-Mar-2019 $5.6M $26.6M Completed Startup
1. Early Stage VC (Series A) 03-Jan-2017 $21M $21M Completed Startup
To view Marius Pharmaceuticals’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Marius Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an oral testosterone replacement therapy designed for hypogonadism or testosterone deficiency. The company'
Drug Delivery
Raleigh, NC
23 As of 2026

Charlottesville, VA
 

Irving, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Marius Pharmaceuticals Competitors (4)

One of Marius Pharmaceuticals’s 4 competitors is Rivus Pharmaceuticals, a Venture Capital-Backed company based in Charlottesville, VA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Rivus Pharmaceuticals Venture Capital-Backed Charlottesville, VA
Biote Medical Corporation Irving, TX
Ro Venture Capital-Backed New York, NY
Found (Social/Platform Software) Accelerator/Incubator Backed Holland Village, Singapore
To view Marius Pharmaceuticals’s complete competitors history, request access »

Marius Pharmaceuticals Patents

Marius Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022277557-A1 Preferred oral testosterone undecanoate therapy to achieve testosterone replacement treatment Active 19-May-2021
AU-2022277557-B2 Preferred oral testosterone undecanoate therapy to achieve testosterone replacement treatment Active 19-May-2021
AU-2024227786-A1 Preferred oral testosterone undecanoate therapy to achieve testosterone replacement treatment Active 19-May-2021
AU-2024227786-B2 Preferred oral testosterone undecanoate therapy to achieve testosterone replacement treatment Active 19-May-2021
CA-3219547-A1 Preferred oral testosterone undecanoate therapy to achieve testosterone replacement treatment Pending 19-May-2021 A61P5/26
To view Marius Pharmaceuticals’s complete patent history, request access »

Marius Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Marius Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Himanshu Shah Family Office Family Office Minority
To view Marius Pharmaceuticals’s complete investors history, request access »

Marius Pharmaceuticals FAQs

  • When was Marius Pharmaceuticals founded?

    Marius Pharmaceuticals was founded in 2016.

  • Where is Marius Pharmaceuticals headquartered?

    Marius Pharmaceuticals is headquartered in Raleigh, NC.

  • What is the size of Marius Pharmaceuticals?

    Marius Pharmaceuticals has 23 total employees.

  • What industry is Marius Pharmaceuticals in?

    Marius Pharmaceuticals’s primary industry is Drug Delivery.

  • Is Marius Pharmaceuticals a private or public company?

    Marius Pharmaceuticals is a Private company.

  • What is the current valuation of Marius Pharmaceuticals?

    The current valuation of Marius Pharmaceuticals is .

  • What is Marius Pharmaceuticals’s current revenue?

    The current revenue for Marius Pharmaceuticals is .

  • How much funding has Marius Pharmaceuticals raised over time?

    Marius Pharmaceuticals has raised $35.6M.

  • Who are Marius Pharmaceuticals’s investors?

    Himanshu Shah Family Office has invested in Marius Pharmaceuticals.

  • Who are Marius Pharmaceuticals’s competitors?

    Rivus Pharmaceuticals, Biote Medical, Ro, and Found (Social/Platform Software) are competitors of Marius Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process